Episode #77: Semaglutide, A GLP-1 Agonist, Showing Success With Weight Loss and Type 2 Diabetes

Dosing Strategies

Dosing strategies for GLP-1 agonists like semaglutide are crucial for effective weight loss and diabetes management. Caleb Greer explains that these medications, originally developed for diabetes, are now used for weight loss by adjusting doses to increase neuropeptides that trigger food aversion responses 1. This gradual increase helps mitigate side effects like nausea, which can occur due to slower gastric emptying 1.

You have to work your way up to the actual effective doses because part of the mechanism of action of these peptides is to increase certain neuro, you know, neuropeptides that elicit food aversion responses.

--- Caleb Greer

Nathalie Niddam notes that semaglutide's development was a breakthrough, allowing for weekly dosing due to its resistance to degradation, which was a significant improvement over earlier medications 2.

   

Duration of Treatment

The duration of treatment with GLP-1 agonists raises questions about long-term use and lifestyle integration. Caleb Greer mentions that while weight regain is common after stopping the medication, maintaining lifestyle changes can reduce dependency on these drugs 3. He shares that some patients use lower doses intermittently to manage their weight after achieving their goals 3.

If people use this opportunity to change their lifestyle, their diet, their way of doing things, and plus all these other things have improved.

--- Nathalie Niddam

Nathalie Niddam emphasizes the importance of lifestyle changes, suggesting that improved insulin sensitivity and dietary habits can lessen the need for continuous medication 4.